Note Regarding Forward-Looking Statements



This Management's Discussion and Analysis of Financial Condition and Results of
Operations ("MD&A") and other parts of this report include "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements are statements other than historical facts
and often address future events or our future performance. Words such as
"anticipate," "estimate," "expect," "project," "intend," "may," "will," "might,"
"plan," "predict," "believe," "should," "could" and similar words or expressions
are intended to identify forward-looking statements, although not all
forward-looking statements contain these identifying words.

Forward-looking statements contained in this MD&A include statements about, among other things:

? specific and overall impacts of the COVID-19 pandemic on our financial

condition and results of operations;

? our beliefs regarding the market and demand for our products or the component

products we resell;

? our ability to develop and launch new products that are attractive to the

market and stimulate customer demand for these products;

? our plans relating to our intellectual property, including our goals of

monetizing, licensing, expanding and defending our patent portfolio;

? our expectations and strategies regarding outstanding legal proceedings and


   patent reexaminations relating to our intellectual property portfolio;

? our expectations with respect to any strategic partnerships or other similar

relationships we may pursue;

? the competitive landscape of our industry;

? general market, economic and political conditions;

? our business strategies and objectives;

our expectations regarding our future operations and financial position,

? including revenues, costs and prospects, and our liquidity and capital

resources, including cash flows, sufficiency of cash resources, efforts to

reduce expenses and the potential for future financings;

our ability to remediate any material weakness, maintain effective internal

? control over financial reporting and satisfy the accelerated and enhanced

disclosure obligations that will apply to us as we transition from a "smaller

reporting company" to a "large accelerated filer" in 2022; and

? the impact of the above factors and other future events on the market price and

trading volume of our common stock.




All forward-looking statements reflect management's present assumptions,
expectations and beliefs regarding future events and are subject to known and
unknown risks, uncertainties and other factors that could cause actual results
to differ materially from those expressed in or implied by any forward-looking
statements. These risks and uncertainties include those described under "Risk
Factors" in Part II, Item 1A of this report. In light of these risks and
uncertainties, our forward-looking statements should not be relied on as
predictions of future events. Additionally, many of these risks and
uncertainties are currently elevated by and may or will continue to be elevated
by the COVID-19 pandemic. All forward-looking statements reflect our
assumptions, expectations and beliefs only as of the date they are made, and
except as required by law, we undertake no obligation to revise or update any
forward-looking statements for any reason.

The following MD&A should be read in conjunction with our condensed consolidated
financial statements and the related notes included in Part I, Item 1 of this
report, as well as our Annual Report on Form 10-K for our fiscal year ended
January 1, 2022 (the "2021 Annual Report") filed with the SEC. All information
presented herein is based on our fiscal calendar, and references to particular
years, quarters, months or periods refer to our fiscal years ended in January or
December and the associated quarters, months and periods of those fiscal years.
Each of the terms the "Company," "Netlist," "we," "us," or "our" as used herein
refers collectively to Netlist, Inc. and its consolidated subsidiaries, unless
otherwise stated.

                                       20

  Table of Contents

Overview

Netlist provides high-performance solid-state drives and modular memory
solutions to enterprise customers in diverse industries. Our NVMe SSDs in
various capacities and form factors and the line of custom and specialty memory
products bring industry-leading performance to server and storage appliance
customers and cloud service providers. Netlist licenses its portfolio of
intellectual property including patents, in server memory, hybrid memory and
storage class memory, to companies that implement Netlist's technology.

During the third quarter of 2022, we recorded net sales of $34.4 million, gross
profit of $2.2 million and net loss of $9.6 million. We have historically
financed our operations primarily with proceeds from issuances of equity and
debt securities and cash receipts from revenues. We have also funded our
operations with a revolving line of credit and term loans under a bank credit
facility. See "Recent Developments" and "Liquidity and Capital Resources" below
for more information.

Recent Developments

SK hynix Agreements

On April 5, 2021, we entered into a Strategic Product Supply and License
Agreement (the "Strategic Agreement") and Product Purchase and Supply Agreement
("Supply Agreement") with SK hynix, Inc., a South Korean memory semiconductor
supplier ("SK hynix"). Both agreements have a term of 5 years. Under the
Strategic Agreement, (a) we have granted to SK hynix worldwide, non-exclusive,
non-assignable licenses to certain of our patents covering memory technologies
and (b) SK hynix has granted to us worldwide, non-exclusive, non-assignable
licenses to its patent portfolio. In addition, the Strategic Agreement provided
for the settlement of all intellectual property proceedings between us and SK
hynix and a fee of $40 million paid to us by SK hynix. In addition, the parties
have agreed to collaborate on certain technology development activities.

Amendment to SVB Credit Agreement



On October 31, 2009, we entered into the SVB Credit Agreement, which provides
for a revolving line of credit of up to $10.0 million, as amended. The SVB
Credit Agreement was most recently amended on April 29, 2022, and the borrowing
base is limited to 85% of eligible accounts receivable, subject to certain
adjustments, and 50% of eligible inventory. Borrowings accrue interest on
advance at a per annum rate equal to the greater of 0.75% above the Prime Rate
or 4.25%. The maturity date is April 28, 2023, as amended.

September 2021 Lincoln Park Purchase Agreement



On September 28, 2021, we entered into the September 2021 Purchase Agreement
with Lincoln Park, pursuant to which we have the right to sell to Lincoln Park
up to an aggregate of $75 million in shares of our common stock over the
36-month term of the September 2021 Purchase Agreement subject to the conditions
and limitations set forth in the September 2021 Purchase Agreement.

During 2021, Lincoln Park purchased an aggregate of 1,550,000 shares of our
common stock for a net purchase price of $10.9 million under the September 2021
Purchase Agreement. In connection with the purchases, we issued to Lincoln Park
an aggregate of 20,809 shares of our common stock as additional commitment
shares in noncash transactions. During the nine months ended October 1, 2022,
Lincoln Park purchased an aggregate of 650,000 shares of our common stock for a
net purchase price of $3.7 million under the September 2021 Purchase Agreement.
In connection with the purchases, we issued to Lincoln Park an aggregate
of 7,168 shares of our common stock as additional commitment shares in noncash
transactions.

Economic Conditions, Challenges and Risks


Our performance, financial condition and prospects are affected by a number of
factors and are exposed to a number of risks and uncertainties. We operate in a
competitive and rapidly evolving industry in which new risks emerge

                                       21

Table of Contents



from time to time, and it is not possible for us to predict all of the risks we
may face, nor can we assess the impact of all factors on our business or the
extent to which any factor or combination of factors could cause actual results
to differ from our expectations. See the discussion of certain risks that we
face under "Risk Factors" in Part II, Item 1A of this report.

Impact of COVID-19 on our Business



The impact of the coronavirus disease ("COVID-19") pandemic will have on our
consolidated results of operations is uncertain. Although we initially observed
demand increases in our products, we anticipate that the global health crisis
caused by COVID-19 may negatively impact business activity across the globe. We
will continue to actively monitor the situation and may take further actions
altering our business operations that we determine are in the best interests of
our employees, customers, suppliers, and stakeholders, or as required by
federal, state, or local authorities. It is not clear what the potential effects
of such alterations or modifications may have on our business, consolidated
results of operations, financial condition, and liquidity.

Results of Operations

Net Sales and Gross Profit

Net sales and gross profit for the three and nine months ended October 1, 2022, and October 2, 2021 were as follows (dollars in thousands):



                                               Three Months Ended                       Nine Months Ended
                                           October 1,      October 2,       %       October 1,      October 2,       %
                                              2022            2021        Change       2022            2021        Change
Net product sales                          $    34,424    $     26,749       29%   $    139,982    $     66,009      112%
License fee                                          -               -        0%              -          40,000    (100%)
Net sales                                       34,424          26,749       29%        139,982         106,009       32%

Gross profit - product sales               $     2,180    $      2,508     (13%)   $     10,291    $      6,874       50%
Gross margin percentage - product sales             6%              9%     

                 7%             10%
Gross profit                               $     2,180    $      2,508     (13%)   $     10,291    $     46,874     (78%)
Gross margin percentage                             6%              9%                       7%             44%


Net Sales

Net sales include (i) resales of component products including DIMMs, SSDs, and
dynamic random-access memory ("DRAM ICS" or DRAM) products, and sales of our
high-performance memory subsystems and (ii) an upfront non-refundable fee
pursuant to the Strategic Agreement with SK hynix entered into on April 5, 2021.

Net product sales increased by approximately $7.7 million during the third
quarter of 2022 compared to the same quarter of 2021, primarily as a result of a
$12.4 million increase in re-sale of SK hynix products and a $4.9 million
increase in sale of Netlist's flash and SSD products, offset by a $9.6 million
decrease in sales of low-profile memory subsystem products.

Net product sales increased by approximately $74.0 million during the first nine
months of 2022 compared to the same period in 2021, primarily as a result of a
$84.0 million increase in re-sale of SK hynix products and a $8.1 million
increase in sale of Netlist's flash and SSD products, offset by a $18.0 million
decrease in sales of low-profile memory subsystem products.

Gross Profit and Gross Margin


Product gross profit decreased by $0.3 million during the third quarter of 2022
compared to the same quarter of 2021 primarily as a result of softer pricing
environment and product sales mix. Product gross profit increased during the
first nine months of 2022 compared to the same period of 2021 due primarily to
higher sales across all product groups.

                                       22

Table of Contents

Product gross margin percentage decreased between the periods as a result of the change in our product mix and increased component product resales as a percentage of revenue.

Operating Expenses

Operating expenses for the three and nine months ended October 1, 2022, and October 2, 2021, were as follows (dollars in thousands):



                                            Three Months Ended                      Nine Months Ended
                                       October 1,       October 2,       %      October 1,      October 2,       %
                                          2022             2021        Change      2022            2021        Change
Research and development               $     2,550     $      2,038       25%  $      7,679    $      5,222       47%
Percentage of net product sales                 7%               8%                      5%              8%

Intellectual property legal fees $ 5,577 $ 8,461 (34%) $ 11,716 $ 14,585 (20%) Percentage of net product sales

                16%              32%                      8%             22%

Selling, general and administrative $ 3,767 $ 2,590 45% $ 11,429 $ 7,639 50% Percentage of net product sales

                11%              10%                      8%             12%


Research and Development

Research and development expenses increased during the third quarter and the
first nine months of 2022 compared to the same periods of 2021 due primarily to
an increase in employee headcount, related overhead and new product research.

Intellectual Property Legal Fees


Intellectual property legal fees consist of legal fees incurred for patent
filings, protection and enforcement. Although we expect intellectual property
legal fees to generally increase over time as we continue to protect, defend and
enforce and seek to expand our patent portfolio, these increases may not be
linear but may occur in lump sums depending on the due dates of patent filings
and their associated fees and the arrangements we may make with our legal
advisors in connection with enforcement proceedings, which may include fee
arrangements or contingent fee arrangements in which we would pay these legal
advisors on a scaled percentage of any negotiated fees, settlements or judgments
awarded to us based on if, how and when the fees, settlements or judgments are
obtained. See Note 7 to the condensed consolidated financial statements included
in Part I, Item 1 of this report for further discussion.

Intellectual property legal fees decreased during the third quarter and the first nine months of 2022 compared to the same periods of 2021 due primarily to lower legal expenses incurred to defend our patent portfolio internationally.

Selling, General and Administrative



Selling, general and administrative expenses increased during the third quarter
and the first nine months of 2022 compared to the same periods of 2021 due
primarily to an increase in employee headcount and overhead and outside
services. As a result of the significant increase in the value of our
non-affiliate public float in recent periods, we are a "large accelerated filer"
as of the end of fiscal year ended January 2, 2022 which means that we need to
file our quarterly and annual reports on an accelerated basis and that we are
required to have our independent registered public accounting firm audit and
attest to our internal control over financial reporting. Complying with these
requirements requires us to invest a material amount in enhancing our financial
reporting infrastructure that will cause our selling, general and administrative
expenses to increase in future periods.

                                       23

  Table of Contents

Other Income (Expense), Net

Other income (expense), net for the three and nine months ended October 1, 2022, and October 2, 2021 was as follows (dollars in thousands):



                                          Three Months Ended                        Nine Months Ended
                                      October 1,      October 2,       %      October 1,       October 2,       %
                                         2022            2021        Change      2022             2021        Change

Interest income (expense), net       $         34     $     (125)            $         38      $     (417)
Other income (expense), net                    82             (2)                      74              641

Total other income (expense), net $ 116 $ (127) 191%

$ 112 $ 224 50%




Interest expense, net, in 2021 consisted primarily of interest expense on the
$15 million secured convertible note issued to Samsung Venture Investment Co.
("SVIC Note") in November 2015 and a revolving line of credit under the SVB
Credit Agreement, along with the accretion of debt discounts and amortization of
debt issuance costs on the SVIC Note. The SVIC Note was paid off in the fourth
quarter of 2021 resulting in a decrease in interest expense for the third
quarter and the first nine months of 2022 compared to the same periods of 2021.

Other income, net increased during the third quarter of 2022 compared to the
same quarter of 2021 primarily as a result of a one-time gain from a sanction
judgment. During the first nine months of 2021, other income, net included the
gain on forgiveness of the Paycheck Protection Program Loan of $0.6 million.
This gain was recognized during the second quarter of 2021 resulting in a
decrease in other income for the first nine months of 2022 compared to the same
period of 2021.

Liquidity and Capital Resources



Our primary sources of cash are historically proceeds from issuances of equity
and debt securities and receipts from revenues. In addition, we have received
proceeds from non-recurring engineering and licensing of our patent portfolio,
including as a result of our entry into the SK hynix Strategic Agreement, which
we use to support our operations. We have also funded our operations with a
revolving line of credit under a bank credit facility, and to a lesser extent,
equipment leasing arrangements.

The following tables present selected financial information as of October 1,
2022, and January 1, 2022 and for the first nine months of 2022 and 2021 (in
thousands):

                                                          October 1,      January 1,
                                                             2022            2022

Cash, cash equivalents and restricted cash               $     43,442    $ 

58,479


Convertible promissory note and accrued interest, net               1      

      562
Working capital                                                37,168          52,613


                                                            Nine Months Ended
                                                       October 1,      October 2,
                                                          2022            2021

Net cash provided by (used in) operating activities $ (17,695) $ 20,095 Net cash used in investing activities

                        (396)          

(318)


Net cash provided by financing activities                    3,054         

36,879




During the nine months ended October 1, 2022, net cash used in operating
activities was primarily a result of net loss of $20.4 million, non-cash
adjustments to net loss of $3.1 million, and net cash outflows from changes in
operating assets and liabilities of $0.4 million driven predominantly by an
increase in inventories due to higher purchases to support increased sales and a
decrease in accounts payable, partially offset by a decrease in accounts
receivable and an increase in accrued expenses and other liabilities. Net cash
provided by financing activities during the nine months ended October 1, 2022
primarily consisted of $1.0 million in net borrowings under the SVB Credit
Agreement, $3.7 million in

                                       24

Table of Contents


net proceeds from issuance of common stock under the September 2021 Lincoln Park
Purchase Agreement, $0.3 million in proceeds from exercise of stock options,
offset by $0.6 million in payments of note payable to finance insurance policies
and $1.3 million in payments for taxes related to net share settlement of equity
awards.

During the nine months ended October 2, 2021, net cash provided by operating
activities was primarily a result of net income of $13.1 million, non-cash
adjustments to net income of $1.3 million, and net cash inflows from changes in
operating assets and liabilities of $5.7 million driven predominantly by an
increase in accounts payable due to higher inventory purchases to support
increase in sales and higher legal fees to defend our patent portfolio,
partially offset by an increase in inventories. Net cash provided by financing
activities during the nine months ended October 2, 2021 primarily consisted of
$26.3 million in net proceeds from issuance of common stock under the 2019
Purchase Agreement with Lincoln Park, 2020 Purchase Agreement with Lincoln Park
and First 2021 Lincoln Park Purchase Agreement, $11.1 million in proceeds from
exercise of stock options and warrants and $0.8 million in net borrowings under
the SVB Credit Agreement, partially offset by $1.0 million in payments for taxes
related to net share settlement of equity awards.

Capital Resources

September 2021 Lincoln Park Purchase Agreement



On September 28, 2021, we entered into the September 2021 Purchase Agreement
with Lincoln Park, pursuant to which we have the right to sell to Lincoln Park
up to an aggregate of $75.0 million in shares of our common stock over the
36-month term of the September 2021 Purchase Agreement subject to the conditions
and limitations set forth in the September 2021 Purchase Agreement. As of
October 1, 2022, $60.4 million remains available under the September 2021
Purchase Agreement with Lincoln Park.

SVB Credit Agreement



On October 31, 2009, we entered into the SVB Credit Agreement, which provides
for a revolving line of credit of up to $10.0 million, as amended. The SVB
Credit Agreement was most recently amended on April 29, 2022, and the borrowing
base is limited to 85% of eligible accounts receivable, subject to certain
adjustments, and 50% of eligible inventory. Borrowings accrue interest on
advance at a per annum rate equal to the greater of 0.75% above the Prime Rate
or 4.25%. The maturity date is April 28, 2023, as amended.

As of October 1, 2022, the outstanding borrowings under the SVB Credit Agreement
were $8.0 million with additional borrowing availability of $0.2 million. During
the nine months ended October 1, 2022, we made net borrowings of $1.0 million
under the SVB Credit Agreement.

Sufficiency of Cash Balances and Potential Sources of Additional Capital


We believe our existing balance of cash and cash equivalents together with cash
receipts from revenues, borrowing availability under the SVB Credit Agreement,
the equity financing available under September 2021 Purchase Agreement, funds
raised through other future debt and equity offerings and taking into account
cash expected to be used in our operations, will be sufficient to meet our
anticipated cash needs for at least the next 12 months.

Off-Balance Sheet Arrangements



We do not have any off-balance sheet arrangements that have or are reasonably
likely to have a current or future effect on our financial condition, changes in
financial condition, revenues or expenses, results of operations, liquidity,
capital expenditure or capital resources that is material to investors.

Critical Accounting Policies and Use of Estimates



The preparation of our condensed consolidated financial statements in conformity
with U.S. GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosures of contingent
assets and liabilities at the date of the condensed consolidated financial
statements, and the reported

                                       25

Table of Contents



amounts of net sales and expenses during the reporting period. By their nature,
these estimates and assumptions are subject to an inherent degree of
uncertainty. We base our estimates and assumptions on our historical experience,
knowledge of current conditions and our beliefs of what could occur in the
future considering available information. We review our estimates and
assumptions on an ongoing basis. Actual results may differ from our estimates,
which may result in material adverse effects on our consolidated operating
results and financial position.

Our critical accounting policies and estimates are discussed in Note 2 to the
condensed consolidated financial statements in this report and in the notes to
consolidated financial statements in Part II, Item 8 of our 2021 Annual Report
and in the MD&A in our 2021 Annual Report. There have been no significant
changes to our critical accounting policies since our 2021 Annual Report.

© Edgar Online, source Glimpses